The global bio-identical hormone replacement therapy (BHRT) is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The BHRT is a process of treating hormonal imbalances with bio-identical hormones. The rise in the aging population who are more prone to hormonal imbalance is anticipated to fuel the demand for bio-identical hormone replacement […]